SAN DIEGO -- Rates of certain infections and other adverse effects were substantially higher in patients receiving sodium-glucose cotransporter-2 (SGLT-2) inhibitors when they also had rheumatoid ...

Patients with gout and type 2 diabetes treated with SGLT2 inhibitors not only had reduced numbers of gout flares, but also lived longer compared with other such patients receiving other medications, ...

Only one in five patients hospitalized for heart failure with reduced ejection fraction (HFrEF) receive a prescription for an SGLT2 inhibitor at discharge, according to a contemporary US analysis.

A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery. Testing for acid load in the blood of diabetes sufferers who are taking ...

A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery. Testing for acid load in the blood of diabetes sufferers who are taking ...

SGLT2 inhibitors (gliflozins) were developed as oral antidiabetics. They enhance urinary glucose excretion by inhibiting SGLT-2 (sodium-dependent glucose co-transporter-2) in the renal tubuli. The ...

SEATTLE — A family of blockbuster drugs for managing blood glucose — and now for promoting weight loss — has been linked to exacerbation of macular disease that frequently accompanies diabetes, new ...

A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery. Testing for acid load in the blood of diabetes sufferers who are taking ...

Novel anti-diabetic agents named gliflozins were found to mask a dangerous complication called ketoacidosis at the time of surgery. Blood test has to be done to check ketoacidosis in which there is ...